. Author manuscript; available in PMC: 2014 Feb 11.

Published in final edited form as: Eur J Nutr. 2012 Feb 10;52(1):169–178. doi: 10.1007/s00394-011-0300-6

Table 4.

Association between taurine and incident hypertension and incident diabetes, overall and in controls

Hypertension ^a	Taurine Tertile 1 (35.75–115.00 nmol/mL)	Taurine Tertile 2 (115.01–141.71 nmol/mL)	Taurine Tertile 3 (141.72–300.31 nmol/mL)	P-value
N (yes/no)	45/77	36/77	32/87
Model 1 OR^b (95% CI)	1.00	0.78 (0.45–1.35)	0.63 (0.37–1.09)	0.10
Model 2 OR^c (95% CI)	1.00	0.79 (0.45–1.39)	0.60 (0.34–1.05)	0.07

Diabetes ^a
N (yes/no)	20/126	10/129	12/129
Model 1 OR^b (95% CI)	1.00	0.47 (0.21–1.06)	0.57 (0.26–1.21)	0.13
Model 2 OR^c (95% CI)	1.00	0.37 (0.16–0.89)	0.50 (0.22–1.11)	0.07

In controls only

Hypertension ^a
N CHD controls (yes/no)	14/43	13/49	7/53
Model 1 OR^b (95% CI)	1.00	0.69 (0.31–1.53)	0.40 (0.17–0.96)	0.04
Model 2 OR^c (95% CI)	1.00	0.65 (0.29–1.46)	0.40 (0.17–0.97)	0.04

Prevalent cases of hypertension and diabetes were excluded from the respective analyses

ORs were calculated using unconditional logistic regression adjustment for age.

ORs were calculated using unconditional logistic regression adjusted for age, BMI, case/control status and smoking (no case/control adjustment in controls only analysis).

P-value for trend based on taurine tertiles